Octafluorocyclobutane

From WikiMD's WELLNESSPEDIA


Structural formula of Octafluorocyclobutane

Octafluorocyclobutane, also known as perfluorocyclobutane or PFC-318, is a chemical compound with the formula C_F_. It is a fluorocarbon and a cyclic compound, consisting of a four-membered ring of carbon atoms, each bonded to two fluorine atoms. This compound is notable for its stability and inertness, which are characteristic of perfluorinated compounds.

Properties[edit]

Octafluorocyclobutane is a colorless, odorless gas at room temperature. It has a high molecular weight and a relatively low boiling point of -6.1 °C. The compound is non-flammable and exhibits low toxicity, making it suitable for various industrial applications.

Physical Properties[edit]

  • Molecular formula: C_F_
  • Molar mass: 200.03 g/mol
  • Boiling point: -6.1 °C
  • Melting point: -40 °C
  • Density: 1.55 g/cm_ (at 25 °C)

Chemical Properties[edit]

Octafluorocyclobutane is chemically inert, meaning it does not react easily with other substances. This property is due to the strong carbon-fluorine bonds and the stability of the cyclic structure. It is resistant to acids, bases, and oxidizing agents.

Applications[edit]

Due to its stability and non-reactivity, octafluorocyclobutane is used in various applications:

Environmental Impact[edit]

Octafluorocyclobutane is a greenhouse gas with a high global warming potential (GWP). It is important to manage its emissions to minimize environmental impact. However, its long atmospheric lifetime and low reactivity mean it does not contribute to ozone depletion.

Safety[edit]

While octafluorocyclobutane is non-toxic, it can act as an asphyxiant by displacing oxygen in enclosed spaces. Proper ventilation and handling procedures should be followed to ensure safety.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.